MAPT and frontotemporal dementia: We then used ConsensusPathDB to test whether 42 proteins of the 127 biomarkers that were not bound to any cell and were associated with frontotemporal dementia, Alzheimer’s or Parkinson’s disease play a role in pathways leading to amyloid precursor protein, tau protein or α-synuclein that characterize these diseases.